These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 35351217)
1. Effectiveness of two coronavirus disease 2019 (COVID-19) vaccines (viral vector and inactivated viral vaccine) against severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in a cohort of healthcare workers. Marra AR; Miraglia JL; Malheiros DT; Guozhang Y; Teich VD; da Silva Victor E; Pinho JRR; Cypriano A; Vieira LW; Polonio M; Ornelas RH; de Oliveira SM; Borges Junior FA; Shibata ARO; Schettino GPP; de Oliveira KG; Ferraz Santana RA; de Mello Malta F; Amgarten D; Boechat AL; Trecenti NMZ; Kobayashi T; Salinas JL; Edmond MB; Rizzo LV Infect Control Hosp Epidemiol; 2023 Jan; 44(1):75-81. PubMed ID: 35351217 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Heterologous Coronavirus Disease 2019 (COVID-19) Vaccine Booster Dosing in Brazilian Healthcare Workers, 2021. Marra AR; Miraglia JL; Malheiros DT; Guozhang Y; Teich VD; da Silva Victor E; Rebello Pinho JR; Cypriano A; Vieira LW; Polonio M; Ornelas RH; de Oliveira SM; Borges Junior FA; Oler SCC; Schettino GPP; de Oliveira KG; Ferraz Santana RA; de Mello Malta F; Amgarten D; Boechat AL; Trecenti NMZ; Kobayashi T; Salinas JL; Edmond MB; Rizzo LV Clin Infect Dis; 2023 Feb; 76(3):e360-e366. PubMed ID: 35639918 [TBL] [Abstract][Full Text] [Related]
3. Longer-term effectiveness of a heterologous coronavirus disease 2019 (COVID-19) vaccine booster in healthcare workers in Brazil. Marra AR; Miraglia JL; Malheiro DT; Guozhang Y; Teich VD; Victor EDS; Pinho JRR; Cypriano A; Vieira LW; Polonio M; Ornelas RH; de Oliveira SM; Borges FA; Oler SCC; Ricardo VCV; Maezato AM; Callado GY; Schettino GPP; de Oliveira KG; Santana RAF; Malta FM; Amgarten D; Boechat AL; Kobayashi T; Salinas JL; Edmond MB; Rizzo LV Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e104. PubMed ID: 37396193 [TBL] [Abstract][Full Text] [Related]
4. An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status. Lumley SF; Rodger G; Constantinides B; Sanderson N; Chau KK; Street TL; O'Donnell D; Howarth A; Hatch SB; Marsden BD; Cox S; James T; Warren F; Peck LJ; Ritter TG; de Toledo Z; Warren L; Axten D; Cornall RJ; Jones EY; Stuart DI; Screaton G; Ebner D; Hoosdally S; Chand M; Crook DW; O'Donnell AM; Conlon CP; Pouwels KB; Walker AS; Peto TEA; Hopkins S; Walker TM; Stoesser NE; Matthews PC; Jeffery K; Eyre DW; Clin Infect Dis; 2022 Apr; 74(7):1208-1219. PubMed ID: 34216472 [TBL] [Abstract][Full Text] [Related]
5. Factors Associated with Vaccine Breakthrough Incidence among Health Care Workers Vaccinated with Inactivated SARS-CoV2 Vaccine (CoronaVac). Anshory M; Wahono CS; Pratama MZ; Rahman PA; Nugraha AS; Sekarani A J Res Health Sci; 2022 Jun; 22(2):e00551. PubMed ID: 36511263 [TBL] [Abstract][Full Text] [Related]
6. [The Second Shot of CoronaVac Vaccine May Cause Reduction of Antibody Levels in People who Previously had COVID-19]. Topkaya AE; Keskin AÜ; Dalan AB; Çıragil P Mikrobiyol Bul; 2022 Jan; 56(1):139-142. PubMed ID: 35088968 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study. Hitchings MDT; Ranzani OT; Torres MSS; de Oliveira SB; Almiron M; Said R; Borg R; Schulz WL; de Oliveira RD; da Silva PV; de Castro DB; Sampaio VS; de Albuquerque BC; Ramos TCA; Fraxe SHH; da Costa CF; Naveca FG; Siqueira AM; de Araújo WN; Andrews JR; Cummings DAT; Ko AI; Croda J Lancet Reg Health Am; 2021 Sep; 1():100025. PubMed ID: 34386791 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of BNT162b2 mRNA Coronavirus Disease 2019 (COVID-19) Vaccine Against Acquisition of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Healthcare Workers in Long-Term Care Facilities: A Prospective Cohort Study. Muhsen K; Maimon N; Mizrahi A; Bodenheimer O; Cohen D; Maimon M; Grotto I; Dagan R Clin Infect Dis; 2022 Aug; 75(1):e755-e763. PubMed ID: 34698808 [TBL] [Abstract][Full Text] [Related]
9. Short-term immune response after inactivated SARS-CoV-2 (CoronaVac®, Sinovac) and ChAdOx1 nCoV-19 (Vaxzevria®, Oxford-AstraZeneca) vaccinations in health care workers. Jantarabenjakul W; Chantasrisawad N; Puthanakit T; Wacharapluesadee S; Hirankarn N; Ruenjaiman V; Paitoonpong L; Suwanpimolkul G; Torvorapanit P; Pradit R; Sophonphan J; Putcharoen O Asian Pac J Allergy Immunol; 2022 Sep; 40(3):269-277. PubMed ID: 34717527 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study. Jara A; Undurraga EA; Zubizarreta JR; González C; Pizarro A; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Mosso M; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R Lancet Glob Health; 2022 Jun; 10(6):e798-e806. PubMed ID: 35472300 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of CoronaVac vaccination against COVID-19 development in healthcare workers: real-life data. Copur B; Surme S; Sayili U; Tuncer G; Pehlivanoglu F; Sengoz G Future Microbiol; 2022 Nov; 17():1381-1391. PubMed ID: 36169346 [TBL] [Abstract][Full Text] [Related]
12. Risks of catching COVID-19 according to vaccination status of healthcare workers during the SARS-CoV-2 Delta variant dominant period and their clinical characteristics. Özüdoğru O; Acer Ö; Genç Bahçe Y J Med Virol; 2022 Aug; 94(8):3706-3713. PubMed ID: 35419851 [TBL] [Abstract][Full Text] [Related]
13. Durability of the Effectiveness of Heterologous COVID-19 Vaccine Regimens in Thailand: Retrospective Cohort Study Using National Registration Data. Kumwichar P; Poonsiri C; Botwright S; Sirichumroonwit N; Loharjun B; Thawillarp S; Cheewaruangroj N; Chokchaisiripakdee A; Teerawattananon Y; Chongsuvivatwong V JMIR Public Health Surveill; 2024 Mar; 10():e48255. PubMed ID: 38441923 [TBL] [Abstract][Full Text] [Related]
14. Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021-31 May 2022. Cegolon L; Negro C; Mastrangelo G; Filon FL; Viruses; 2022 Nov; 14(12):. PubMed ID: 36560692 [No Abstract] [Full Text] [Related]
15. Comparison of immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccine (CoronaVac) in previously SARS-CoV-2 infected and uninfected health care workers. Soysal A; Gönüllü E; Karabayır N; Alan S; Atıcı S; Yıldız İ; Engin H; Çivilibal M; Karaböcüoğlu M Hum Vaccin Immunother; 2021 Nov; 17(11):3876-3880. PubMed ID: 34324409 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data. Paris C; Perrin S; Hamonic S; Bourget B; Roué C; Brassard O; Tadié E; Gicquel V; Bénézit F; Thibault V; Garlantézec R; Tattevin P Clin Microbiol Infect; 2021 Nov; 27(11):1699.e5-1699.e8. PubMed ID: 34265462 [TBL] [Abstract][Full Text] [Related]
17. [Efficacy of Homologous and Heterologous Vaccine Applications on SARS-CoV-2 Omicron Variant: Cohort of Manisa Celal Bayar University Healthcare Workers]. Çiçek K; Özkaya Y; Eser E; Buran ZC; Öztürk Arıkan ZÖ; Akçalı S; Erbay Dündar P; Cengiz Özyurt B; Şenol Akar Ş; Özer D; Karadağ Yalçın F Mikrobiyol Bul; 2023 Apr; 57(2):238-251. PubMed ID: 37067208 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Reinfection Rate and Estimated Effectiveness of the Inactivated Whole Virion Vaccine BBV152 Against Reinfection Among Health Care Workers in New Delhi, India. Malhotra S; Mani K; Lodha R; Bakhshi S; Mathur VP; Gupta P; Kedia S; Sankar J; Kumar P; Kumar A; Ahuja V; Sinha S; Guleria R; ; Dua A; Ahmad S; Sathiyamoorthy R; Sharma A; Sakya T; Gaur V; Chaudhary S; Sharma S; Madan D; Gupta A; Virmani S; Gupta A; Yadav N; Sachdeva S; Sharma S; Singh S; Pandey A; Singh M; Jhurani D; Sarkar S; Lokade AK; Mohammad A; Pandit S; Dubey R; Singh AK; Gohar N; Soni D; Bhattacharyya A; Rai S; Tummala S; Gupta I; Shukla S JAMA Netw Open; 2022 Jan; 5(1):e2142210. PubMed ID: 34994793 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of CoronaVac in preventing COVID-19 in healthcare workers. Bayhan GI; Guner R Hum Vaccin Immunother; 2022 Dec; 18(1):2020017. PubMed ID: 35172694 [TBL] [Abstract][Full Text] [Related]
20. [Investigation of Humoral and Cellular Immunity in TOBB ETÜ Hospital Workers After Three Doses of CoronaVac Vaccination and after One Dose of Comirnaty Vaccination Following Two Doses of CoronaVac]. Özyurda F; Ardıçoğlu Akışın Y; Mert T; Poyraz B; Özkan Y; Turan M; Göçmen JS; Yücel A; Akar N Mikrobiyol Bul; 2022 Jul; 56(3):387-403. PubMed ID: 35960233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]